Cerulean Reports Third-Quarter 2014 Corporate Highlights and Financial Results
13. November 2014 16:06 ET
|
Daré Bioscience, Inc.
CAMBRIDGE, Mass., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Cerulean Pharma Inc. (Nasdaq:CERU), a leader in Dynamic Tumor Targeting™, today provided an update on corporate activities during the quarter...
Cerulean to Host Third-Quarter 2014 Conference Call on November 13
30. Oktober 2014 08:01 ET
|
Daré Bioscience, Inc.
CAMBRIDGE, Mass., Oct. 30, 2014 (GLOBE NEWSWIRE) -- Cerulean Pharma Inc. (Nasdaq:CERU), a leader in Dynamic Tumor Targeting™, today announced it will provide an update on corporate activities...